arrow_back Trending Legislation
Share share

September 2024: National Ovarian Cancer Awareness Month in the US

This House Resolution supports designating September 2024 as National Ovarian Cancer Awareness Month. The aim is to boost public knowledge about the symptoms and risks of ovarian cancer, potentially leading to earlier detection and improved treatment outcomes, especially for underserved communities.
Key points
Increased awareness of ovarian cancer can lead to quicker diagnosis, which is vital for survival rates.
There is no reliable early detection test for ovarian cancer, making symptoms often confused with other conditions.
The resolution highlights the need for better access to care and genetic testing, particularly for high-risk groups and minorities.
Support for ovarian cancer research and education is crucial for improving patient outcomes.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Supporting the designation of September 2024 as "National Ovarian Cancer Awareness Month".
Print number: HRES 1508
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
Process start date: 2024-09-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about September 2024: National Ovarian Cancer Awareness Month in the US

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 1508.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-09-25.

What are the main provisions?

Key points include:

  • Increased awareness of ovarian cancer can lead to quicker diagnosis, which is vital for survival rates.
  • There is no reliable early detection test for ovarian cancer, making symptoms often confused with other conditions.
  • The resolution highlights the need for better access to care and genetic testing, particularly for high-risk groups and minorities.
  • Support for ovarian cancer research and education is crucial for improving patient outcomes.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Oversight and Accountability.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HRES 1508

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health